Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”
Yingzhe Zhang. Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”. // Hepatology Research. – 2026. – DOI: 10.1111/hepr.70227. – URL: https://onlinelibrary.wiley.com/doi/10.1111/hepr.70227?af=R
Yingzhe Zhang (2026). Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”. Hepatology Research. https://doi.org/10.1111/hepr.70227
Yingzhe Zhang. “Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”.” Hepatology Research, 2026. doi:10.1111/hepr.70227.
@article{Zhang2026,
title = {Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”},
author = {Zhang, Yingzhe},
journal = {Hepatology Research},
year = {2026},
doi = {10.1111/hepr.70227},
url = {https://onlinelibrary.wiley.com/doi/10.1111/hepr.70227?af=R}
}